Tailored biological treatment for patients with moderate-to-severe psoriasis
Introduction Psoriasis is a common, chronic immune-mediated skin disease frequently
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …
[PDF][PDF] Tailored biological treatment for patients with moderate-to-severe psoriasis
M Maurelli, P Gisondi, G Girolomoni - Immunology, 2022 - core.ac.uk
Introduction: Psoriasis is a common, chronic immune-mediated skin disease frequently
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …
Tailored biological treatment for patients with moderate to severe psoriasis.
M Maurelli, P Gisondi, G Girolomoni - Expert Review of Clinical …, 2022 - europepmc.org
Psoriasis is a common, chronic immune-mediated skin disease frequently associated to
inflammatory and metabolic comorbidities. About 20-30% of patients are affected by …
inflammatory and metabolic comorbidities. About 20-30% of patients are affected by …
Tailored biological treatment for patients with moderate-to-severe psoriasis
M Maurelli, P Gisondi… - Expert review of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Psoriasis is a common, chronic immune-mediated skin disease frequently
associated to inflammatory and metabolic comorbidities. About 20-30% of patients are …
associated to inflammatory and metabolic comorbidities. About 20-30% of patients are …
Tailored biological treatment for patients with moderate-to-severe psoriasis
M Maurelli, P Gisondi, G Girolomoni - EXPERT REVIEW OF CLINICAL …, 2023 - iris.univr.it
Introduction: Psoriasis is a common, chronic immune-mediated skin disease frequently
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …
associated to inflammatory and metabolic comorbidities. About 20–30% of patients are …